Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01596985
Other study ID # P.S.PJ.6.10.GYN
Secondary ID
Status Unknown status
Phase Phase 2
First received May 9, 2012
Last updated May 11, 2012
Start date November 2010
Est. completion date May 2013

Study information

Verified date May 2012
Source Plasma Surgical Inc
Contact Horace Roman, MD PhD
Phone 0033232888643
Email Horace.Roman@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: To compare loss of ovarian parenchyma following ovarian endometrioma ablation using the PlasmaJet system versus cystectomy, using postoperative examination by 3D ultrasound.

Design: Prospective comparative study. Setting: Two experienced surgeons practicing in two University tertiary referral centers.

Patients: Fifty women with no previous history of ovarian surgery managed for unilateral ovarian endometrioma > 30 mm in diameter.

Interventions: Endometrioma ablation by plasma energy using the PlasmaJet system and ovarian tissue sparing cystectomy.

Main Outcome Measures: 3D ultrasound assessment of postoperative reduction in ovarian volume and antral follicle count (AFC) .


Description:

The management of ovarian endometriomas in women wishing to conceive remains challenging. Recent data suggest that excising endometriomas by ovarian tissue sparing cystectomy does not avoid inadvertent removal of ovarian parenchyma surrounding the cyst, particularly in enlarged cysts. Although several authors question whether the ovarian parenchyma immediately surrounding the cyst may still be functional, there is little doubt that postoperative fertility could be significantly impaired by loss of ovarian cortex and provokes the question as to whether pregnancy should be initiated before performing a cystectomy, whenever this scenario is possible. However ovarian surgery cannot always be delayed to the postpartum period, numerous women require endometrioma management while not seeking an immediate pregnancy and still wish to conserve their procreative capabilities.

After a period of some years during which cystectomy appeared to be the best surgical technique in the treatment of ovarian endometriomas in women wishing to become pregnant, recent data have suggested that ablation of the inner layer of the endometrioma may be a valuable alternative technique, as long as the energy employed avoids thermal diffusion to surrounding ovarian tissue. The Department of Gynecology at the University Hospital in Rouen, France have introduced ablation by plasma energy using the PlasmaJet system (Plasma Surgical Ltd, Abingdon, UK) and have already been able to report encouraging results based on non comparative pilot studies and on retrospective "before and after" comparative study.

The aim of the study is to prospectively compare loss of ovarian parenchyma and decrease in antral follicle count (AFC) following ovarian endometrioma ablation using plasma energy versus cystectomy, when performed by only two expert surgeons. Postoperative examination is carried out by 3D ultrasound.


Recruitment information / eligibility

Status Unknown status
Enrollment 50
Est. completion date May 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Age between 18 and 45 years;

- Surgery required by pelvic pain or infertility related to endometriosis;

- Clinical and imaging data proving unilateral ovarian endometrioma which diameter exceeds 30 mm.

Exclusion Criteria:

- Previous surgery on ovaries or IVF procedures;

- Bilateral endometriomas;

- Pregnancy

- Woman not French speaker.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ablation using the PlasmaJet system
Ablation of the inner surface of the cyst is then performed using the PlasmaJet system in coagulation mode set at 40, at a distance averaging 5 mm from the tip of the handpiece, and with an exposure time limited to 1 to 2 seconds on each site. Care is taken not to leave any untreated sites and to ablate the edges of the invagination site and the corresponding peritoneal implants on the adjacent broad ligament.
Cystectomy
Surgical excision of an ovarian endometrioma by cystectomy involves three distinct areas, each requiring a different excision procedure. Area A from where cyst invagination originates, measures 1 cm² on average and is revealed by lysing adhesions between the ovary and the adjacent broad ligament, leading to the characteristic "chocolate fluid" evacuation. The excision by scissors of area A allows the surgeon to identify a cleavage plane close to the cyst wall, which can be followed without significant bleeding (area B). Should adhesions appear in the cleavage plane, they are coagulated and cut, so as not to strip the ovarian cortex. Close to the ovarian hilus, for complete cyst removal, adhesions require coagulation using bipolar current and section by scissors (area C).

Locations

Country Name City State
France University Hospital Clermont Ferrand Auvergne
France University Hospital Rouen Seine-Maritime

Sponsors (1)

Lead Sponsor Collaborator
Plasma Surgical Inc

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Loss of ovarian volume Evaluation of ovarian volumes of both the operated and the contralateral healthy ovary using a tridimensional ultrasound by vaginal route. The volume of each ovary expressed in cm³ was estimated using the formula D1 x D2 x D3 x p / 6. The Mann and Whitney test is performed to compare measurements made on the operated ovaries vs. those made on the contralateral ovaries. 3 months postoperatively
Secondary Decrease in ovarian antral follicles count (AFC) Evaluation of antral follicle counts in both the operated and the contralateral, healthy ovary, using tridimensional ultrasound. The Mann and Whitney test is performed to compare the decrease in AFC depending on surgical procedure. 3 months postoperatively
Secondary Antimullerian Hormone level (AMH) AMH level are measured before and 3 months after the surgery to evaluate the decrease in AMH level depending on surgical technique. 3 months postoperatively
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03717870 - Surgery and ART For Endometrioma N/A
Recruiting NCT02623244 - The Association Between Ovarian Endometrioma and Lower Urinary Tract Symptoms
Recruiting NCT04151173 - Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma N/A
Completed NCT00989118 - Randomized Study on Endometrioma Treatment Phase 3
Completed NCT06219044 - Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization N/A
Not yet recruiting NCT05837624 - Estetrol/Drospirenone to Reduce the Average Size of Endometriomas Phase 4
Not yet recruiting NCT03585309 - The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts. N/A
Recruiting NCT02350452 - Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas N/A
Completed NCT03615352 - Laparoscopic Ovarian Cystectomy Versus Aspiration and Coagulation in Ovarian Endometrioma N/A
Recruiting NCT05104086 - Ultrasound Elastography in Diffferentiation of Endometriomas and Hemorrhagic Cysts N/A
Not yet recruiting NCT03784404 - Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI Phase 4
Recruiting NCT05279209 - Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma N/A
Recruiting NCT05357924 - Evaluating Ovarian Reserve After Conventional Laparoscopy Versus Robotic Surgery for Bilateral Endometrioma N/A
Recruiting NCT05291624 - Ultrasonographic and Surgical Assessment of Endometriosis by AAGL 2021 Endometriosis Classification